Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Corticotrophin Releasing Factor 2 for the Treatment of Worsening Heart Failure (WHF) - The CRAFT-WHF Study

NCT06815471 is registered in ClinicalTrials.gov with Corteria Pharmaceuticals as lead sponsor.

NCT NCT06815471
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06815471 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Corticotrophin Releasing Factor 2 for the Treatment of Worsening Heart Failure (WHF) - The CRAFT-WHF Study
Lead sponsor
Corteria Pharmaceuticals
Phase
Phase 2
Overall status
Suspended
Start date
August 7, 2025
Completion date
December 31, 2026
Enrollment
300 (estimated)
Sites
55

Conditions

As the registry lists them; a condition with its own page is linked.

worsening heart failure